Drug Type Oncolytic product |
Synonyms- |
Target |
Mechanism CD46 inhibitors(Membrane cofactor protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Adze Biotechnology, Inc.Startup |
Active Organization Adze Biotechnology, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Ovarian Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Prostatic Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |